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Every year, malaria causes an estimated 250-500 million
clinical cases worldwide, resulting in nearly a million deaths.
Despite growing awareness and substantial public-health
efforts aimed at reducing the global malaria burden, more
than a billion people remain at risk of contracting the disease,
and control remains elusive: there is currently no licensed
vaccine, and resistance has developed to nearly all available
antimalarial drugs [1]. A study published recently by Lasonder
and colleagues in PLoS Pathogens [2] applies a proteomics-
based reverse genetics approach to identify proteins expressed
specifically in the stages that immediately precede human
infection, resulting in the identification of new candidates for
drugs and vaccines that might prevent infection by
Plasmodium falciparum.
Malaria is caused by Plasmodium parasites, which have a
complex life cycle (Figure 1). Sexual parasite forms, or
gametocytes, that are generated at low frequency during
the blood stage are taken up in a mosquito bloodmeal.
Gamete fertilization occurs in the mosquito midgut, and
the resulting zygote develops into an ookinete, which
penetrates the wall of the midgut and becomes an oocyst.
The parasite then reproduces asexually within this
membrane-bound form, generating thousands of oocyst-
derived sporozoites (ODS). These are released into the
mosquito hemocoel upon rupture of the oocyst, and
subsequently invade the salivary glands. When the infected
mosquito bites a new mammalian host, salivary gland
sporozoites (SGS) are injected, which migrate from the
skin into blood vessels and then circulate to the liver.
Hepatocyte invasion initiates the liver stage. Extensive
differentiation and multiplication ensues, with each liver-
stage parasite yielding tens of thousands of merozoites.
Asexual reproduction then occurs within erythrocytes,
leading to the clinical symptoms that occur during the
blood stage of the disease. When these cells rupture, new
waves of merozoites are released into the human
bloodstream to invade fresh erythrocytes.
In recent years, high-throughput approaches to identifying
novel drug and vaccine targets have been made possible by
genome sequencing of Plasmodium species. The genomes of
P. falciparum, the deadliest human parasite [3], and that of
a model rodent species, P. yoelii [4], were published in
2002. These were followed by the genomes of rodent species
P. berghei and P. chabaudi in 2005 [5], and those of P. vivax
and P. knowlesi, two other species that infect humans, in
2008 [6,7]. These studies subsequently enabled several
transcriptome and proteome analyses (reviewed in [8]).
Most of these efforts were focused on P. falciparum blood-
stage parasites that can be cultured in vitro, and on rodent
parasite model species. Because of technical difficulties in
working with liver-stage forms, our knowledge of the genes
and proteins expressed during this stage is less complete.
However, intervention strategies aimed at pre-erythrocytic
stages (sporozoite and liver-stage parasites) are considered
promising because of the low number of parasites
transmitted by the mosquito [9] and the fact that sterile
immunity against the pre-erythrocytic forms of both human
and rodent parasites can be induced by immunization with
attenuated parasites [10,11]. A better understanding of
mosquito and liver-stage parasites is necessary to develop
and improve on pre-erythrocytic stage interventions.
Functional genomic studies such as those by Lasonder et al.
[2] will further our knowledge of this important period of
malaria pathogenesis.I Id de en nt ti if fy yi in ng g   m ma al la ar ri ia a   c co on nt tr ro ol l   t ta ar rg ge et ts s
While ODS are morphologically indistinguishable from the
mature SGS, these forms carry out very different processes
(Figure 1). ODS travel through the hemolymph of the
mosquito to find, bind and traverse the salivary glands into
the secretory cavity. In contrast, SGS released from the
mosquito salivary gland into the vertebrate host have to
navigate the skin and circulatory system of the host to reach
the liver, and then traverse several liver cells before
ultimately forming a parasitophorous vacuole membrane
around itself within a hepatocyte. SGS and ODS should
therefore have distinct protein repertoires to mediate their
diverse functions. Proteins that are more abundant in ODS
could have roles in sporozoite maturation within the oocyst,
in egress, and in salivary gland recognition and invasion.
Conversely, proteins that are more abundant in SGS could be
involved in the establishment of infection in the human host,
with possible roles in migration through skin, binding and
traversing hepatic cells, and invading hepatocytes. In
accordance with these different biological properties, SGS
display a dramatically enhanced ability to invade hepatocytes
and to establish infection in the vertebrate host when
compared to ODS (reviewed in [12]), and the transcriptional
profiles of ODS and SGS are different [13,14].
With this hypothesis in mind, Lasonder and colleagues
isolated ODS and SGS by hand-dissection of infected
mosquitoes and compared their proteomes by high-
throughput nano-liquid chromatography tandem mass
spectrometry [2]. Many of the 250 proteins identified
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Pre-erythrocytic stages of the Plasmodium life cycle analyzed by comparative proteomics in the study of Lasonder et al. [2]. Mosquito stages are shown
on a pale pink background; stages in the vertebrate host on a pale blue background. ( (a a) ) Oocyst derived sporozoites (ODS) are generated within the
oocyst embedded in the mosquito midgut. ( (b b) ) ODS egress from the oocyst and invade salivary glands. ( (c c) ) Salivary gland sporozoites (SGS) are
transmitted to the vertebrate host and invade hepatocytes. Other stages included for reference include gametocyte maturation, gamete fertilization and
zygote formation, which precede invasion of the mosquito midgut by the ookinete; and the liver and blood stages. The stage-specific proteins
characterized by Lasonder et al. [2] (in red ovals) are depicted at the point of the cycle where they are predicted to function. Modified from Vickerman
and Cox [26].
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MAL8P1.66exclusively in mosquito stages (as determined by
comparison with previously published data by the same
group [15]), are annotated as hypothetical, meaning that
their function cannot be inferred by sequence homology.
Some of these are likely to carry out Plasmodium-specific
functions relevant to malaria pathogenesis. While many
proteins were detected in multiple mosquito stages,
approximately 24% of the proteins in the SGS fraction and
15% of those in the ODS fraction were stage-specific.
Importantly, the majority of proteins reported to be involved
in sporozoite development and invasion of host cells were
observed in the ODS and SGS proteomes. Proteins with
multiple roles in sporozoite maturation and development
(such as the inner membrane complex protein (IMC1),
circumsporozoite surface protein (CSP) and
thrombospondin-related anonymous protein (TRAP)) were
identified in both stages. Conversely, the membrane antigen
erythrocyte binding-like protein (MAEBL), which has been
reported to function in attachment and invasion to the
salivary gland, was detected at much higher levels in the
ODS proteome, and proteins with functions in hepatocyte
traversal or invasion (for example, sporozoite microneme
proteins essential for cell traversal (SPECT1 and 2), cell-
traversal protein for ookinetes and sporozoites (CelTOS),
secreted protein with altered thrombospondin domain
(SPATR), apical membrane antigen (AMA1), and the surface
proteins P36p and P36) were exclusive or more abundant in
the SGS proteome.
The study yielded three lists of proteins: those exclusive to
the mosquito-stage proteome but shared between the
different sporozoite forms, and those highly differentially
enriched in either the SGS or the ODS proteome. On the
basis of expression profiling, lack of functional annotation,
presence of orthologs in the rodent species P. berghei, and
bioinformatic predictions of parasite-specific protein
secretion signals, eight proteins were selected for further
analysis by targeted deletion of their orthologs in
P. berghei. In total, six mutant lines were successfully
generated (two genes could not be deleted, suggesting
essential functions in blood-stage parasites). All mutant
lines showed normal asexual development and gametocyte
and ookinete production. Three of the six lines displayed
no difference in the number of oocysts or sporozoites
formed or in their ability to establish productive infections
in mice when compared to wild-type parasites. This
suggests that either the function of the corresponding
proteins is not essential for mosquito- or liver-stage
development, or alternatively that functional redundancy
interfered with the identification of a phenotypic effect in
the mutant lines.
The other three parasite lines (one mutant for an ODS-
specific protein, and two with gene deletions for proteins
shared by ODS and SGS) were unable to infect mice.
Although all three mutant lines generated normal numbers
of oocysts, they displayed distinct developmental defects.
First, disruption of the P. berghei ortholog of PF14_0435
prevented sporozoite formation within otherwise
morphologically normal oocysts. This early phenotype is
reminiscent of sporogonic defects observed in loss-of-
function mutants of the major sporozoite surface protein
CSP (reviewed in [12]), and is consistent with expression of
this protein by ODS. In contrast, deletion of the MAL8P1.66
ortholog resulted in a drastically reduced number of ODS
that could nonetheless invade salivary glands and traverse
hepatocytes. In spite of this, the resulting sporozoites were
not infective to mice, possibly because the MAL8P1.66
orthologue is expressed by liver-stage parasites [16] and,
therefore, may have an essential role in liver-stage
development as well. Thus, the function of MAL8P1.66
might be required for a process that is important throughout
the mosquito and liver stages. 
Lastly, the parasite line mutated in the ortholog of
P. falciparum PFD0425w generated normal numbers of
ODS but displayed an egress defect that resulted in the
accumulation of sporozoites within the oocyst and a low
number of sporozoites in the hemolymph and the salivary
glands. The authors point out that this phenotype is similar
to that observed in mutants of the egress cysteine protease
(ECP1) [17] and in parasite lines that carry mutations in the
region II-plus domain of CSP [18]. Mosquitoes infected with
this line were unable to cause infection in mice, although
ODS collected mechanically from these mosquitoes and
injected intravenously yielded typical levels of parasitemia in
mice, leading Lasonder et al. [2] to speculate that this
protein is not likely to have an essential role in later stages of
the parasite life cycle. 
P. falciparum PFD0425w, as well as its P. yoelii ortholog
have been previously characterized as mosquito- and liver-
stage specific proteins [19,20]. Importantly, volunteers
immunized with irradiated sporozoites mount an antibody
response against this protein, although antibody reactivity
did not correlate with protection from malaria [21]. More
recently, PFD0425w was identified as having a transient
pattern of upregulation upon co-incubation of SGS with
hepatocytes at 37°C, similar to that of other proteins that
have been implicated in hepatocyte invasion [22].
Moreover, the presence of a signal peptide on PFD0425w,
the immunofluorescent localization of the protein, and its
role in sporozoite invasion and traversal of hepatocytes
(suggested by antibody inhibition studies) indicate that
this protein, like CSP, is displayed on the surface of SGS.
Western blots suggest that PFD0425w might be
proteolytically cleaved after exposure to host hepatocytes,
as are AMA1 and TRAP [23]. From these results, Siau et al.
[22] named the protein sporozoite invasion-associated
protein-1 (SIAP-1), and proposed that its main function
might be related to gliding, in apparent contradiction to
the conclusions of Lasonder et al. [2].
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Lasonder  et al. [2] regarding the function of PFD0425w
correspond to variations among species or reflect technical
aspects of the assays was addressed by recent work from
Matuschewski and his group (Engelmann et al. [24]). This
new study confirms the oocyst egress defect resulting from
the disruption of PFD0425w reported by Lasonder et al. [2].
However, using a green fluorescent protein-tagged version
of the P. berghei ortholog of PFD0425w, Engelmann et al.
[24] were able to detect low numbers of sporozoites in the
hemocoel. Furthermore, in agreement with the
interpretation of Siau et al. [22], their data support the
notion that PFD0425w is involved in gliding locomotion
within the mosquito, as the few sporozoites detected in the
hemocoel displayed severely reduced motility, which may in
turn result in their reduced ability to invade salivary glands.
The authors note that both egress from oocysts and
movement through the hemocoel are related to sporozoite
locomotion, tying together the apparently disparate
phenotypes assigned to this protein. The new data confirm
that the protein is localized to the apical tip of both ODS and
SGS, and, in agreement with previous reports, that the
expression of the gene encoding P. berghei SIAP-1 is
maximal in young oocysts and diminishes upon hepatocyte
invasion [24]. Finally, when large numbers of ODS and SGS
isolated from the P. berghei SIAP-1 mutant were injected
into mice, a low percentage of the animals developed
parasitemia, in concordance with the results obtained by
Lasonder  et al. with P. yoelii sporozoites obtained by
mechanical disruption of oocysts [2].
F Fo ol ll lo ow wi in ng g   t th he e   s sp po or ro oz zo oi it te e   t tr ra ai il l
The work described above validates the usefulness of a
proteome-reverse genetic approach for the characterization
of proteins specific to a particular stage of the life cycle.
Eight proteins were selected from the initial lists, and of the
six that could be successfully disrupted, half displayed
unique phenotypes, reflecting the participation of the
proteins in different events during the sporogonic and liver
stages of the parasite's life cycle. The list of sporozoite-
specific proteins is bound to contain many other putative
vaccine and drug targets. From the point of view of human
disease,  P. falciparum-specific proteins that lack rodent
orthologs might be of special interest as they could encode
functions needed exclusively for human pathogenesis.
However, understanding the in vivo roles of these proteins
will require the development of novel approaches.
These case studies in functional genomics show just how
rapidly genome-scale technologies can change the face of
translational research. The P. falciparum genome was
published in 2002, and the subsequent six years have seen
the discovery of a candidate for a vaccine aimed at
preventing malaria infection during pregnancy as well as
significant follow-up research validating this finding
(reviewed in [25]). Recently, combined transcriptome and
proteome analyses of the liver stages of P. yoelii revealed
that, among others, proteins involved in the type II fatty-
acid synthesis metabolic pathway are upregulated, and more
importantly demonstrated that inhibitors of this pathway
are effective drugs against liver-stage parasites [16]. Now,
the sporozoite stages are following suit, pushing new vaccine
and drug targets into the research pipeline.
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